Biopharmaceutical Testing Services | Charles River

lot & final drug product release 

All products entering local or global pharmaceutical markets require Good Manufacturing Practice (GMP) testing to ensure that they are released in accordance with regional and global regulatory authority guidelines. Release testing packages comprise a range of studies previously validated to demonstrate compliance of a product.  The Biopharmaceutical Services (BPS) groups at Charles River provides product release testing services for client-derived and BPS-derived intermediate and final drug products. The BPS group provides release services for the European Union (EU), US, and other regulatory-distinct markets, and can act as a single site for global release testing for clients.

We provide a full range of support for our clients, from addressing biosafety concerns and analyzing potency using suitable bioassays to determine purity and other biochemical characteristics. Our commitment to providing rapid turnaround times for all testing helps minimize the period between production and release.

Key Features

  • EU Release
  • Technology Transfer
  • Biochemical Analysis
  • Potency

 


Charles River and WuXi AppTec to Combine

For more information please call:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Jul 13 - New Genetic Toxicology Assays with...
Jun 09 - Expanded Immunogenicity Testing in...
Jul 29-Jul 29 - Cambridge, MA - Harvard University Life Science Exhibit
Sep 13-Sep 15 - San Diego, CA - Annual Biotech Symposium on Biotechnology-Derived Thera...
Aug 24-Aug 27 - South Carolina, USA - Charles River LAL Workshop
view all
Director, Clinical Specialist Sales 
Manager Corporate Consolidation Wilmingto...
IT Specialist II - Web Development  
Senior Tax Analyst Wilmington, MA

Charles River Laboratories, Inc.